Search research articles
Contact Us
Filters
Showing results (21-30 of 145) with videos related to
Page
of 15
Sort By:
Cancer
|
November 1, 1985
Clinical features and natural history of intramedullary spinal cord metastasis
J L Grem, J Burgess, D L Trump
Prostate Cancer and Prostatic Diseases
|
April 4, 2007
Docetaxel-induced Meibomian duct inflammation and blockage leading to chalazion formation
S Gupta, C G Silliman, D L Trump
Archives of Internal Medicine
|
March 1, 1982
Gynecomastia in men following antineoplastic therapy
D L Trump, M D Pavy, S Staal
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1993
Importance of continued testicular suppression in hormone-refractory prostate cancer
C D Taylor, P Elson, D L Trump
The New England Journal of Medicine
|
August 2, 1979
Discordance between plasma calcitonin and tumor-cell mass in medullary thyroid carcinoma
D L Trump, G Mendelsohn, S B Baylin
JAMA
|
July 26, 1976
Quinacrine ochronosis and rheumatoid arthritis
M J Egorin, D L Trump, C W Wainwright
Cancer Chemotherapy and Pharmacology
|
January 1, 1992
Choice of starting dose and escalation for phase I studies of antitumor agents
J S Penta, G L Rosner, D L Trump
Radiographics : a Review Publication of the Radiological Society of North America, Inc
|
January 1, 1991
Complications of hepatic arterial infusion chemotherapy
M A Pozniak, S G Babel, D L Trump
American Journal of Clinical Oncology
|
June 1, 1997
Megestrol acetate in the treatment of hormone refractory prostate cancer
J L Osborn, D C Smith, D L Trump
The Urologic Clinics of North America
|
November 1, 1992
Metastatic bladder cancer. Natural history, clinical course, and consideration for treatment
G D Steinberg, D L Trump, K B Cummings
Page
of 15
Search research articles
Search
Showing results (21-30 of 145) with videos related to
Sort By:
Page
of 15
Cancer
|
November 1, 1985
Clinical features and natural history of intramedullary spinal cord metastasis
J L Grem, J Burgess, D L Trump
Prostate Cancer and Prostatic Diseases
|
April 4, 2007
Docetaxel-induced Meibomian duct inflammation and blockage leading to chalazion formation
S Gupta, C G Silliman, D L Trump
Archives of Internal Medicine
|
March 1, 1982
Gynecomastia in men following antineoplastic therapy
D L Trump, M D Pavy, S Staal
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1993
Importance of continued testicular suppression in hormone-refractory prostate cancer
C D Taylor, P Elson, D L Trump
The New England Journal of Medicine
|
August 2, 1979
Discordance between plasma calcitonin and tumor-cell mass in medullary thyroid carcinoma
D L Trump, G Mendelsohn, S B Baylin
JAMA
|
July 26, 1976
Quinacrine ochronosis and rheumatoid arthritis
M J Egorin, D L Trump, C W Wainwright
Cancer Chemotherapy and Pharmacology
|
January 1, 1992
Choice of starting dose and escalation for phase I studies of antitumor agents
J S Penta, G L Rosner, D L Trump
Radiographics : a Review Publication of the Radiological Society of North America, Inc
|
January 1, 1991
Complications of hepatic arterial infusion chemotherapy
M A Pozniak, S G Babel, D L Trump
American Journal of Clinical Oncology
|
June 1, 1997
Megestrol acetate in the treatment of hormone refractory prostate cancer
J L Osborn, D C Smith, D L Trump
The Urologic Clinics of North America
|
November 1, 1992
Metastatic bladder cancer. Natural history, clinical course, and consideration for treatment
G D Steinberg, D L Trump, K B Cummings
Page
of 15